Both in Pharmaceuticals
Disc Medicine vs Xenon Pharmaceuticals
Over the past year IRON returned −2.5% and XENE returned −11.3%; their daily moves had a correlation of 0.22.
IRON −2.5% XENE −11.3%Growth of $1, one year, split-adjusted
| Metric | IRON | XENE |
|---|---|---|
| Price | $82.84 | $37.54 |
| Market cap | $3.68B | $3.64B |
| Today | −0.43% | +3.30% |
| 1 month | +26.6% | +0.9% |
| 6 months | +25.6% | −33.0% |
| Year to date | +4.3% | −16.2% |
| 1 year | −5.4% | −11.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $658.4M | $930.7M |
| Dividend yield | — | — |
| Volatility (60d) | 75.6% | 82.4% |
| Short % of float | 22.8% | 8.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).